Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section.
暂无分享,去创建一个
M. Helewa | E. R. Luther | J. Dansereau | D. Farine | I. Lange | A. K. Joshi | W. Wassenaar | G. Horbay | P. Griffin | M. Schulz | T. Doran | E. Luther
[1] C. AbouZahr,et al. Maternal Mortality: A Global Factbook , 1991 .
[2] P. V. van Dongen,et al. Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[3] R. Rochat,et al. Maternal Mortality in the United States: Report From the Maternal Mortality Collaborative , 1988, Obstetrics and gynecology.
[4] I. Mackenzie,et al. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2α, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section , 1994 .
[5] A. Chang,et al. A randomised double blind comparison of Syntometrine® and Syntocinon® in the management of the third stage of labour , 1995, British journal of obstetrics and gynaecology.
[6] W. Wassenaar,et al. Effect of carbetocin, a long‐acting oxytocin analog on the postpartum uterus , 1992, Clinical pharmacology and therapeutics.
[7] J. Whitehead,et al. A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.
[8] M. Ohlin,et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women , 1990 .
[9] W. Doesburg,et al. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour , 1991 .
[10] D. Sackett. Bias in analytic research. , 1979, Journal of chronic diseases.
[11] E. Royston,et al. Preventing Maternal Deaths , 1989 .
[12] W. Prendiville,et al. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. , 1993, BMJ.